On the 29th March 2019, a vote took place on the proposed first stage of the renegotiated Brexit deal by the United Kingdom (UK) Parliament. The plan was subsequently rejected and as a result, the extended deadline agreed during the EU Summit on the
On 13th March, the United Kingdom (UK) Parliament voted in favour of leaving the European Union (EU) with a Brexit deal. A further vote took place on 14th March in favour of extending Article 50 (the UK/EU Withdrawal Agreement) beyond 29th March, how
The UK Parliament voted on 15th January 2019 rejecting the EU/UK Brexit deal and therefore, a number of unknown variables regarding the current Brexit situation remain.
Why You Should be Conducting Your Clinical Trials in Australia.
Important Considerations When Initiating a Clinical Study
PCI Clinical Services and our Guests discuss Brexit and its impact on Clinical Trials in the EU and UK
When it comes to pharmaceutical and biopharmaceutical supply chain expertise who do you trust?
Your bridge between life-changing therapies and patients